Biodiscovery Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.75 M
as on 24-10-2024
- Revenue 16.61%
(FY 2023)
- Profit 12.93%
(FY 2023)
- Ebitda 147.83%
(FY 2023)
- Net Worth 49.78%
(FY 2023)
- Total Assets 27.50%
(FY 2023)
About Biodiscovery Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.75 M.
Anil Kumar and Manisha serve as directors at the Company.
- CIN/LLPIN
U74999HR2018PTC073225
- Company No.
073225
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2018
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Biodiscovery Lifesciences Private Limited offer?
Biodiscovery Lifesciences Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Diclofenac, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Antibiotic Injection, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Arthritic Drugs, Sexual Wellness Products, Fertility Enhancer.
Who are the key members and board of directors at Biodiscovery Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Kumar  | Additional Director | 15-Mar-2024 | Current |
| Manisha | Additional Director | 15-Mar-2024 | Current |
Financial Performance of Biodiscovery Lifesciences.
Biodiscovery Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.61% increase. The company also saw a substantial improvement in profitability, with a 12.93% increase in profit. The company's net worth Soared by an impressive increase of 49.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biodiscovery Lifesciences?
In 2023, Biodiscovery Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Jan 2024 | ₹0.75 M | Open |
How Many Employees Work at Biodiscovery Lifesciences?
Unlock and access historical data on people associated with Biodiscovery Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biodiscovery Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biodiscovery Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
